1. Home
  2. BLLN vs VEON Comparison

BLLN vs VEON Comparison

Compare BLLN & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$93.23

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo VEON Ltd. ADS

VEON

VEON Ltd. ADS

SELL

Current Price

$80.43

Market Cap

5.3B

ML Signal

SELL

Company Overview

Basic Information
Metric
BLLN
VEON
Founded
2016
1992
Country
United States
United Arab Emirates
Employees
N/A
N/A
Industry
Medical Specialities
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
5.3B
IPO Year
2025
2010

Fundamental Metrics

Financial Performance
Metric
BLLN
VEON
Price
$93.23
$80.43
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
★ $129.00
$86.87
AVG Volume (30 Days)
★ 561.3K
153.5K
Earning Date
08-05-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 103.40
N/A
EPS
★ 0.48
N/A
Revenue
★ $305,112,000.00
N/A
Revenue This Year
$49.05
$15.96
Revenue Next Year
$26.16
$8.09
P/E Ratio
$204.98
★ $6.15
Revenue Growth
★ 99.97
N/A
52 Week Low
$61.96
$42.60
52 Week High
$150.44
$78.83

Technical Indicators

Market Signals
Indicator
BLLN
VEON
Relative Strength Index (RSI) 38.68 78.31
Support Level $88.85 $50.12
Resistance Level $98.14 N/A
Average True Range (ATR) 7.14 3.16
MACD -2.29 0.26
Stochastic Oscillator 6.44 91.03

Price Performance

Historical Comparison
BLLN
VEON

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About VEON VEON Ltd. ADS

VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan. Its telecommunications and digital services include voice, fixed broadband, data and cloud services.

Share on Social Networks: